|Positive WB detected in||HeLa cells, MCF-7 cells, U-937 cells|
|Positive IP detected in||HeLa cells|
|Positive IHC detected in||human colon cancer tissue, human spleen tissue, human liver tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||human tonsillitis tissue|
|Western Blot (WB)||WB : 1:500-1:1000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
The immunogen of 22225-1-AP is MPO Fusion Protein expressed in E. coli.
|Cited Reactivity||human, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||MPO fusion protein Ag17564|
|Calculated molecular weight||745 aa, 84 kDa|
|Observed molecular weight||59 kDa|
|GenBank accession number||BC130476|
|Gene ID (NCBI)||4353|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
The MPO gene encodes myeloperoxidase, a lysosomal hemoprotein located in the azurophilic granules of polymorphonuclear (PMN) leukocytes and monocytes. In response to stimulation, MPO is activated into a transient intermediate with potent antimicrobial oxidizing abilities(PMID:17650507). The mRNA is translated into a single protein of 90 kDa, which displays enzymatic activity and undergoes proteolytic maturation into a heavy chain of 59 kDa and a light chain of 13.5 kDa; these subunits then dimerize into the mature tetramer and the mature MPO is a heterotetramer composed of two identical heavy chains and two identical light chains(PMID:12773517). The 24-kDa material had a map identical to that of 13.5 kDa subunit and represents a dimer of the 13.5 kDa subunit (PMID:3008892). Defects in MPO are the cause of myeloperoxidase deficiency (MPOD). It has 3 isoforms produced by alternative splicing. This antibody is specific to MPO.
|Product Specific Protocols|
|WB protocol for MPO antibody 22225-1-AP||Download protocol|
|IHC protocol for MPO antibody 22225-1-AP||Download protocol|
|IF protocol for MPO antibody 22225-1-AP||Download protocol|
|IP protocol for MPO antibody 22225-1-AP||Download protocol|
|Click here to view our Standard Protocols|
A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation.
α7-nAChR Activation Has an Opposite Effect on Healing of Covered and Uncovered Wounds.
Toxicol Appl Pharmacol
Curcumin plays neuroprotective roles against traumatic brain injury partly via Nrf2 signaling.
Emodin attenuated severe acute pancreatitis via the P2X ligand‑gated ion channel 7/NOD‑like receptor protein 3 signaling pathway.
Cancer Biol Med
Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis.
Acta Pharm Sin B
A new perspective of triptolide-associated hepatotoxicity: the relevance of NF- κ B and NF- κ B-mediated cellular FLICE-inhibitory protein.